As the manufacturers of the only FDA approved total artificial heart (TAH), our company has always been focused on helping patients live longer and healthier lives. Until recently this has been through the TAH, a device that can allow patients experiencing end stage biventricular heart failure to survive and recuperate while awaiting a suitable donor heart for transplant. In light of the current crisis we expanded that mission to include other more basic supplies of which there is a critical shortage. Using the same technical expertise and quality systems that enable us to offer the TAH, we are proud to be supply these medical grade products to our hospital partners as well as directly to the public whose access has been severely restricted by the current shortages.
To learn more about us and what we do, please visit https://syncardia.com/.